The Podcast discuss a new publication tha introduces new consensus-based guidelines for using botulinum toxin A (BTA) to treat myofascial pelvic pain and other types of pelvic floor dysfunction. Developed through a modified Delphi method involving a panel of experts, these guidelines address the lack of standardization for this off-label treatment. The experts categorize BTA as a third-line therapy to be used when conservative treatments like physical therapy or vaginal relaxants fail. Detailed recommendations cover patient selection, specific muscle palpation, and a preferred total dosage of 100 to 200 units. This framework aims to improve clinical safety and provide a structured methodology for future medical research.